Related Experiment Video

Updated: Jun 3, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Recombinant Vaccinia Virus MVA for Generation and Analysis of T Cell Responses Against Tumor Associated Antigens

I Drexler1, K Heller, M Ohlmann

  • 1Institut für Molekulare Medizin, Bavarian Nordic Research Institute, Neuherberg, Germany.

Methods in Molecular Medicine
|March 11, 2011
PubMed

Insights

Live attenuated viruses effectively induce immunity. Recombinant viral vectors show promise for cancer immunotherapy by presenting tumor antigens to the immune system, mimicking infection.

Area of Science:

  • Immunology
  • Virology
  • Oncology

Background:

  • Live attenuated viruses are effective vaccine platforms.
  • Tumor-associated antigens (TAA) are increasingly identified for cancer vaccine development.
  • Live recombinant viral vectors offer a promising delivery system for cancer immunotherapy.

Purpose of the Study:

  • To explore the potential of live recombinant viral vectors for cancer immunotherapy.
  • To evaluate the use of viral vectors for presenting tumor-associated antigens (TAA).

Main Methods:

  • Utilizing live attenuated viruses as vaccine vectors.
  • Engineering viral vectors for high-level expression of target genes.
  • Leveraging the intrinsic immune-activating properties of viral vectors.

Main Results:

  • Viral vectors can efficiently present tumor-associated antigens (TAA).
  • High-level gene expression is achievable with viral vector systems.
  • Viral vectors activate immune control systems, mimicking natural infection.

Conclusions:

  • Live recombinant viral vectors are suitable for cancer immunotherapy.
  • These vectors hold promise for eliciting protective immunity against cancer by presenting TAA.

More Related Videos

Methodology for the Efficient Generation of Fluorescently Tagged Vaccinia Virus Proteins09:27

Methodology for the Efficient Generation of Fluorescently Tagged Vaccinia Virus Proteins

Published on: January 17, 2014

In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model07:05

In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model

Published on: November 28, 2017

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Vaccinations01:51

Vaccinations

Overview
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.